Novel Drug Discovery
Rapid Drug Development
Proprietary positions in the regulation of cellular chronological lifespan allow Chronos Therapeutics’ research to be advanced into pre-clinical stages of development for age-related diseases quickly and efficiently.
Chronos Therapeutics’ drug development strategy is focused in two areas:
- Repositioning FDA/EMA approved drugs.
- Discovery of novel proprietary lead candidates.
- ALS (Lou Gehrig’s Disease)
- Parkinson’s Disease
- Alzheimer’s Disease
- Orphan Diseases